PIVOT-10: Phase II study of bempegaldesleukin plus nivolumab in cisplatin-ineligible advanced urothelial cancer

  1. Huddart, R.A.
  2. Siefker-Radtke, A.O.
  3. Balar, A.V.
  4. Bilen, M.A.
  5. Powles, T.
  6. Bamias, A.
  7. Castellano, D.
  8. Khalil, M.F.
  9. Van Der Heijden, M.S.
  10. Koshkin, V.S.
  11. Pook, D.W.
  12. Ozguroglu, M.
  13. Santiago, L.
  14. Zhong, B.
  15. Chien, D.
  16. Lin, W.
  17. Tagliaferri, M.A.
  18. Loriot, Y.
Journal:
Future Oncology

ISSN: 1744-8301 1479-6694

Year of publication: 2021

Volume: 17

Issue: 2

Pages: 137-149

Type: Article

DOI: 10.2217/FON-2020-0795 GOOGLE SCHOLAR lock_openOpen access editor